TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation
David A. Morrow(University of California, San Francisco), Eugene Braunwald(Mass General Brigham), Andrew Charlesworth(University of Bristol), James A. de Lemos(Universität Hamburg), Robert P. Giugliano(Thrombolysis in Myocardial Infarction Study Group), Sabina A. Murphy(Brigham and Women's Hospital), Carolyn H. McCabe(Brigham and Women's Hospital), Richard Cairns(University of Nottingham), Elliott M. Antman(Brigham and Women's Hospital)
Cited by 1,574
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.1k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k